Premarket Mover: NRX Pharmaceuticals Inc (NRXP) Down 3.67%

Friday, November 25, 2022 08:30 AM | InvestorsObserver Analysts

Mentioned in this article

NRX Pharmaceuticals Inc (NRXP) is down Friday morning, with the stock decreasing -3.67% in pre-market trading to 1.05. NRXP's short-term technical score of 58 indicates that the stock has traded more bullishly over the last month than 58% of stocks on the market. In the Biotechnology industry, which ranks 116 out of 146 industries, NRXP ranks higher than 67% of stocks. NRX Pharmaceuticals Inc has risen 37.97% over the past month, closing at $0.81 on October 28. During this period of time, the stock fell as low as $0.81 and as high as $1.34. NRXP has an average analyst recommendation of Strong Buy. The company has an average price target of $3.00.

NRXP has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on NRXP!
NRX Pharmaceuticals Inc has a Long-Term Technical rank of 86. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 14% of the market scoring higher. In the Biotechnology industry which is number 127 by this metric, NRXP ranks better than 127% of stocks.

Important Dates for Investors in NRXP:

-NRX Pharmaceuticals Inc is set to release earnings on 2/12/2023. Over the last 12 months, the company has reported EPS of $-2.09. -We do not have a set dividend date for NRX Pharmaceuticals Inc at this time. Click Here To Get The Full Report on NRX Pharmaceuticals Inc (NRXP)

Share this article: